The Food and Drug Administration today authorized, and CDC recommended, a second Pfizer or Moderna COVID-19 vaccine booster dose for adults aged 50 and older at least four months after an initial booster dose. The agencies also authorized and recommended a second Moderna booster dose for certain immunocompromised adults, and a second Pfizer booster dose for certain immunocompromised individuals aged 12 or older. Based on an analysis of emerging data, a second booster dose “could help increase protection levels for these higher-risk individuals,” said Mark Peters, M.D., director of FDA’s Center for Biologics Evaluation and Research. 

In other vaccination news, President Biden today announced plans to expand the Federal Retail Pharmacy program to 20,000 more pharmacies by April 19 so that 90% of Americans can access a COVID-19 vaccine site within 5 miles. He also announced almost $100 million in Department of Health and Human Services funding to help older adults and people with disabilities get to a vaccination site; and plans to stand up 12 new federally run mass vaccination sites. 

Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Headline
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug…